Research
Print page Print page
Switch language
Rigshospitalet - a part of Copenhagen University Hospital
Published

Characteristics of finasteride users in comparison with nonusers: A Nordic nationwide study based on individual-level data from Denmark, Finland, and Sweden

Research output: Contribution to journalJournal articleResearchpeer-review

DOI

  1. Tramadol use in Norway: A register-based population study

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Multi-centre, multi-database studies with common protocols: Lessons learnt from the IMI PROTECT project

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Use of quinine and mortality-risk in patients with heart failure-a Danish nationwide observational study

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. The use of valproic acid and multiple sclerosis

    Research output: Contribution to journalJournal articleResearchpeer-review

  1. Timing of radiotherapy after radical prostatectomy (RADICALS-RT): a randomised, controlled phase 3 trial

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Novel functions of the luteinizing hormone/chorionic gonadotropin receptor in prostate cancer cells and patients

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. AZGP1 Protein Expression in Hormone-Naive Advanced Prostate Cancer Treated with Primary Androgen Deprivation Therapy

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Validation of the four-miRNA biomarker panel MiCaP for prediction of long-term prostate cancer outcome

    Research output: Contribution to journalJournal articleResearchpeer-review

  • Thora Majlund Kjaerulff
  • Annette Kjaer Ersbøll
  • Eero Pukkala
  • Kristian Bolin
  • Anders Green
  • Martha Emneus
  • Klaus Brasso
  • Peter Iversen
  • Lau Caspar Thygesen
View graph of relations

PURPOSE: Published epidemiological studies on the association between finasteride use and the risk of male breast cancer have been inconclusive due to methodological limitations including a few male breast cancer cases included. Determinants of male breast cancer have been studied, but it remains unexplored whether these are also related to finasteride use and thereby constitute potential confounders. This study aimed to assess whether there are differences between finasteride users and nonusers with regard to numerous potential confounders.

METHODS: In total, 246 508 finasteride users (≥35 years) were identified in the prescription registries of Denmark (1995-2014), Finland (1997-2013), and Sweden (2005-2014). An equal number of nonusers were sampled. The directed acyclic graph (DAG) methodology was used to identify potential confounders for the association between finasteride and male breast cancer. A logistic regression model compared finasteride users and nonusers with regard to potential confounders that were measurable in registries and population surveys.

RESULTS: Finasteride users had higher odds of testicular abnormalities (odds ratio [OR] 1.40; 95% confidence interval [CI] 1.36-1.44), obesity (1.31; 1.23-1.39), exogenous testosterone (1.61; 1.48-1.74), radiation exposure (1.22; 1.18-1.27), and diabetes (1.07; 1.04-1.10) and lower odds of occupational exposure in perfume industry or in high temperature environments (0.93; 0.87-0.99), living alone (0.89; 0.88-0.91), living in urban/suburban areas (0.97; 0.95-0.99), and physical inactivity (0.70; 0.50-0.99) compared to nonusers.

CONCLUSIONS: Systematic differences between finasteride users and nonusers were found emphasizing the importance of confounder adjustment of associations between finasteride and male breast cancer.

Original languageEnglish
JournalPharmacoepidemiology and Drug Safety
Volume29
Issue number4
Pages (from-to)453-460
Number of pages8
ISSN1053-8569
DOIs
Publication statusPublished - Apr 2020

ID: 60880178